Darmerica

(Image: Getty/Rzarek)

Darmerica recalls API lots due to label mix-up

By Vassia Barba

Darmerica recalls two lots of product labeled as quinacrine, a compound used as a sclerosing agent, which were instead found to contain a treatment for malaria.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All